Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Valerie, Chiang"'
Autor:
Hugo W.F. Mak, MBBS, MRes[Med], Elaine Y.L. Au, FRCPA, Maegan H.Y. Yeung, MBBS, Valerie Chiang, MBBS, Ki Lam, FRCPA, Jane C.Y. Wong, FHKCP, Heather H.F. Yeung, MSc, Eric Y.T. Chan, FRCPath, Chak-sing Lau, MD, FRCP, Philip H. Li, MD, FRCP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100297- (2024)
Background: Basophil activation tests (BATs) are useful in identifying culprits of perioperative anaphylaxis (PA), but their utility remains limited due to technical limitations, cost, and availability. Being able to prioritize patients with likely h
Externí odkaz:
https://doaj.org/article/1c00faebba5042eba1e9e1a335c46563
Autor:
James K.Y. Hooi, MBChB, Marshall C.H. Low, BPharm, Jonathan C.L. To, BPharm, Hugo W.F. Mak, MBBS, Mandy M. Choi, BPharm, Chris C.P. Tam, BPharm, Raymond W.M. Mak, MSc, Vincent K.C. Wong, MPharm, Timo C.C. Chan, MClinPharm, Andrew W.T. Li, MClinPharm, Charlie C.Y. Mak, MClinPharm, Valerie Chiang, MBBS, Gordon K.H. Chu, MBBS, Jane C.Y. Wong, MBBS, Philip H. Li, MD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 12, Pp 101003- (2024)
Background: Mislabelled penicillin allergies are associated with a myriad of adverse outcomes and development of anti-microbial resistance. With the overwhelming need for specialist allergy services, pharmacist initiatives such as the Hong Kong Penic
Externí odkaz:
https://doaj.org/article/40564bcbb38e46ba9601042f9976b105
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background Incorrect drug ‘allergy’ labels remain a global public health concern. Identifying regional trends of drug allergy labeling can guide appropriate public health interventions, but longitudinal or population drug allergy studies
Externí odkaz:
https://doaj.org/article/63ea2c52c8e4477289ad0d997e5b6288
Autor:
Hugo W.F. Mak, MBBS MRes(Med), Valerie Chiang, MBBS, Elsie T.S. Chan, BNurs, Elaine Lee, MSc, Jackie S.H. Yim, MSc, Dorothy L.Y. Lam, MSc, Philip H. Li, MD, FRCP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 2, Pp 100243- (2024)
Background: Chronic spontaneous urticaria (CSU) is an immunologic condition with an estimated prevalence of 0.1%. For CSU that is poorly controlled despite the use of antihistamines, omalizumab is the only treatment approved and recommended by intern
Externí odkaz:
https://doaj.org/article/a39a38c2f3314f6f8d05511a8502ec77
Autor:
Ankur Kumar Jindal, MD, DM, Valerie Chiang, MBBS, Prabal Barman, MD, Archan Sil, MD, Sanchi Chawla, MSc, Elaine Y.L. Au, MBBS, FRCPA, Amit Rawat, MD, Philip H. Li, MD, FRCP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 1, Pp 100179- (2024)
Background: Hereditary angioedema (HAE) is a rare genetic disease. Patients with type II HAE have normal or elevated C1-inhibitor (C1-INH) levels but C1-INH protein is dysfunctional. C1-INH function requires careful sample handling and technical expe
Externí odkaz:
https://doaj.org/article/1b88a503c1b74753a1449c2532407aea
Autor:
Hugo W. F. Mak, Shi Yeung Ho, Jane C. Y. Wong, Valerie Chiang, Elaine Lee, Jackie S. H. Yim, Birgitta Y. H. Wong, Philip H. Li
Publikováno v:
Frontiers in Allergy, Vol 5 (2024)
IntroductionOlfactory dysfunction (OD) is common among patients with chronic rhinosinusitis (CRS). Validated and culturally specific tests, such as the “Sniffin’ Sticks” test (SST) and the TIB Smell Identification Test (TIBSIT), are crucial for
Externí odkaz:
https://doaj.org/article/754a63544c954ff09ebdb4859b6f7ad0
Publikováno v:
Frontiers in Allergy, Vol 4 (2024)
BackgroundExcipient allergy is a rare, but potentially lethal, form of drug allergy. Diagnosing excipient allergy remains difficult in regions without mandatory drug ingredient disclosure and is a significant barrier to drug safety.ObjectiveTo invest
Externí odkaz:
https://doaj.org/article/0fe80bbe587a4792ad5f8e3f814a3c3a
Autor:
Jane C.Y. Wong, MBBS, FHKCP, Valerie Chiang, MBBS, Dorothy L.Y. Lam, MSc, Elaine Lee, MSc, Ki Lam, MBBS, FRCPA, Elaine Y.L. Au, FRCPA, FHKCPath, Philip H. Li, MD, FRCP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 4, Pp 100166- (2023)
Background: With no approved long-term prophylaxis (LTP) for the prevention of hereditary angioedema (HAE) attacks in Hong Kong, patients rely on compassionate use programs and drug trials. Moreover, studies regarding the use and efficacy of LTP in A
Externí odkaz:
https://doaj.org/article/6b9b9958f7c3421b9fafa812eb34a3d6
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 9, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/7bff30ecb10041f6b60e4d940690b56f
Autor:
Valerie Chiang, MBBS, Hugo W.F. Mak, MBBS, Maegan H.Y. Yeung, BA, MBBS, Andy K.C. Kan, MBBS, Elaine Y.L. Au, MBBS, FRCPA, Philip H. Li, MBBS, FRCP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 3, Pp 100127- (2023)
Background: Anaphylaxis is a life-threatening allergic reaction that poses a considerable burden on populations across all ethnicities and age groups. The Hong Kong Multidisciplinary Anaphylaxis Management Initiative (HK-MAMI) was established to stre
Externí odkaz:
https://doaj.org/article/7736dc827f9448d1b992832e04fcbea7